5.4.2.12: phosphoglycerate mutase (2,3-diphosphoglycerate-independent)
This is an abbreviated version!
For detailed information about phosphoglycerate mutase (2,3-diphosphoglycerate-independent), go to the full flat file.
Word Map on EC 5.4.2.12
-
5.4.2.12
-
mutases
-
2-phosphoglycerate
-
ipgms
-
2,3-bisphosphoglycerate-independent
-
cofactor-dependent
-
2,3-bisphosphoglycerate
-
mexicana
-
brugia
-
malayi
-
phosphoenzyme
-
dikinase
-
flux-controlling
-
filariasis
-
medicine
-
drug development
- 5.4.2.12
- mutases
- 2-phosphoglycerate
-
ipgms
-
2,3-bisphosphoglycerate-independent
-
cofactor-dependent
- 2,3-bisphosphoglycerate
- mexicana
-
brugia
- malayi
- phosphoenzyme
- dikinase
-
flux-controlling
- filariasis
- medicine
- drug development
Reaction
Synonyms
2,3-biphosphoglycerate-independent phosphoglycerate mutase, 2,3-diphosphoglycerate-independent phosphoglycerate mutase, 2,3BPG-independent PGAM, 3-phosphoglycerate mutase, apgM, co-factor-independent phosphoglycerate mutase, cofactor independent phosphoglycerate mutase, cofactor-independent phosphoglycerate mutase, cofactor-independent phosphoglycerate mutase 1, EC 2.7.5.3, EC 5.4.2.1, independent PGAM, independent PGM, iPGAM, iPGM, MJ0010, MJ1612, PGAM, PGM, PH0037, SSO0417
ECTree
Advanced search results
Application
Application on EC 5.4.2.12 - phosphoglycerate mutase (2,3-diphosphoglycerate-independent)
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
drug development
TbiPGAM is an attractive molecular target for drug development, the apoenzyme conformation described here provides opportunities for its use in structure-based drug design approaches
medicine
drug target for novel anti-filarial therapies that selectively target the Wolbachia endosymbiont of Brugia malayi
medicine
the enzyme is a potential vaccine candidate against visceral leishmaniasis